Concepedia

Christopher Polk

CP

Statistics

Publications

8

Citations

467

H-Index

8

Active since

2019

Affiliations

Atrium Medical Cente(Current)

Emory University

Mayo Clinic in Florida

Grady Memorial Hospital

Humanigen (United States)

Christopher Polk is an author at Atrium Medical Cente specializing in medicine, clinical trials, and influenza vaccines.

ORCID

Top concepts

Publications per year

2019–2025

8

Publications

8

Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections

Renee Ackley, Danya Roshdy, J. Wayne Meredith et al. · Antimicrobial Agents and Chemotherapy · 2020 · 151 citations · Full text

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial

John H. Beigel, Evgenia Aga, Marie‐Carmelle Elie et al. · The Lancet Respiratory Medicine · 2019 · 109 citations · Full text

, , +6

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 70 citations · Full text

, , +6

Global monkeypox case hospitalisation rates: A rapid systematic review and meta-analysis

Michael DeWitt, Christopher Polk, John Williamson et al. · EClinicalMedicine · 2022 · 62 citations · Full text

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Zelalem Temesgen, Charles D. Burger, Jason V. Baker et al. · 2021 · 34 citations · Full text

1–5 of 8